Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery

The purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs. Ten dogs (Group A) undergoing elective unilateral mastectomy surgery were included in the study. To induce and m...

Full description

Bibliographic Details
Main Authors: Claudia Interlandi, Simona Di Pietro, Giovanna L. Costa, Filippo Spadola, Nicola M. Iannelli, Daniele Macrì, Vincenzo Ferrantelli, Francesco Macrì
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/12/22/3134
_version_ 1797466121203351552
author Claudia Interlandi
Simona Di Pietro
Giovanna L. Costa
Filippo Spadola
Nicola M. Iannelli
Daniele Macrì
Vincenzo Ferrantelli
Francesco Macrì
author_facet Claudia Interlandi
Simona Di Pietro
Giovanna L. Costa
Filippo Spadola
Nicola M. Iannelli
Daniele Macrì
Vincenzo Ferrantelli
Francesco Macrì
author_sort Claudia Interlandi
collection DOAJ
description The purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs. Ten dogs (Group A) undergoing elective unilateral mastectomy surgery were included in the study. To induce and maintain anesthesia, subjects received propofol and sevoflurane at varying doses; analgesia was performed with remifentanil. After three months, the same subjects (Group B) underwent contralateral mastectomy and received the same anesthetic protocol with the addition of cisatracurium at a dosage of 0.2 mg/kg<sup>−1</sup>. The following parameters were monitored during anesthesia: heart rate, systolic blood pressure, end-tidal CO<sub>2</sub>, oxygen saturation, halogenate requirement, and rectal temperature at baseline (T<sup>0</sup>), induction (T<sup>1</sup>), 5 (T<sup>5</sup>), 10 (T<sup>10</sup>), 15 (T<sup>15</sup>), 20 (T<sup>20</sup>), 25 (T<sup>25</sup>), 30 (T<sup>30</sup>), and 35 (T<sup>35</sup>) time points. In Group A, halogenate requirement was reduced at all the time points other than T1 (<i>p</i> < 0.001); in Group B, the percentage of halogenate requirement was already reduced at T<sup>1</sup> and remained constant during the experimental period, showing no significant intragroup differences. The dose requirements of sevoflurane and propofol varied significantly between the two groups, with significantly lower dosages in the Group B (the cisatracurium-treated group). Moreover, patients treated with cisatracurium showed a stable anesthetic plan. The nondepolarizing-muscle-relaxant cisatracurium besylate could be considered a useful adjunct to anesthetic protocols.
first_indexed 2024-03-09T18:31:18Z
format Article
id doaj.art-78d564be732d4401b388715b4bf101ce
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-09T18:31:18Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-78d564be732d4401b388715b4bf101ce2023-11-24T07:28:47ZengMDPI AGAnimals2076-26152022-11-011222313410.3390/ani12223134Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy SurgeryClaudia Interlandi0Simona Di Pietro1Giovanna L. Costa2Filippo Spadola3Nicola M. Iannelli4Daniele Macrì5Vincenzo Ferrantelli6Francesco Macrì7Department of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyDepartment of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyDepartment of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyDepartment of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyDepartment of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyZooprophylactic Institute, Via Gino Marinuzzi 3, 90100 Palermo, ItalyZooprophylactic Institute, Via Gino Marinuzzi 3, 90100 Palermo, ItalyDepartment of Veterinary Sciences, University of Messina, Polo Universitario Annunziata, Via Palatucci Annunziata, 98168 Messina, ItalyThe purpose of the present study was to test whether the addition of cisatracurium in combination with propofol and sevoflurane would result in a change in doses of used anesthetic drugs. Ten dogs (Group A) undergoing elective unilateral mastectomy surgery were included in the study. To induce and maintain anesthesia, subjects received propofol and sevoflurane at varying doses; analgesia was performed with remifentanil. After three months, the same subjects (Group B) underwent contralateral mastectomy and received the same anesthetic protocol with the addition of cisatracurium at a dosage of 0.2 mg/kg<sup>−1</sup>. The following parameters were monitored during anesthesia: heart rate, systolic blood pressure, end-tidal CO<sub>2</sub>, oxygen saturation, halogenate requirement, and rectal temperature at baseline (T<sup>0</sup>), induction (T<sup>1</sup>), 5 (T<sup>5</sup>), 10 (T<sup>10</sup>), 15 (T<sup>15</sup>), 20 (T<sup>20</sup>), 25 (T<sup>25</sup>), 30 (T<sup>30</sup>), and 35 (T<sup>35</sup>) time points. In Group A, halogenate requirement was reduced at all the time points other than T1 (<i>p</i> < 0.001); in Group B, the percentage of halogenate requirement was already reduced at T<sup>1</sup> and remained constant during the experimental period, showing no significant intragroup differences. The dose requirements of sevoflurane and propofol varied significantly between the two groups, with significantly lower dosages in the Group B (the cisatracurium-treated group). Moreover, patients treated with cisatracurium showed a stable anesthetic plan. The nondepolarizing-muscle-relaxant cisatracurium besylate could be considered a useful adjunct to anesthetic protocols.https://www.mdpi.com/2076-2615/12/22/3134cisatracurium besylatepropofolsevofluranedogsurgery
spellingShingle Claudia Interlandi
Simona Di Pietro
Giovanna L. Costa
Filippo Spadola
Nicola M. Iannelli
Daniele Macrì
Vincenzo Ferrantelli
Francesco Macrì
Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
Animals
cisatracurium besylate
propofol
sevoflurane
dog
surgery
title Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
title_full Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
title_fullStr Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
title_full_unstemmed Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
title_short Effects of Cisatracurium in Sevoflurane and Propofol Requirements in Dog-Undergoing-Mastectomy Surgery
title_sort effects of cisatracurium in sevoflurane and propofol requirements in dog undergoing mastectomy surgery
topic cisatracurium besylate
propofol
sevoflurane
dog
surgery
url https://www.mdpi.com/2076-2615/12/22/3134
work_keys_str_mv AT claudiainterlandi effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT simonadipietro effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT giovannalcosta effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT filippospadola effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT nicolamiannelli effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT danielemacri effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT vincenzoferrantelli effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery
AT francescomacri effectsofcisatracuriuminsevofluraneandpropofolrequirementsindogundergoingmastectomysurgery